IWD: 100 Female Founders : Women's Health Innovators
IWD Celebration + Annual Nexus Community Member Awards
Join us on the 5th March for a panel of amazing female founders
As well as to celebrate 10x female founders in the Nexus community, award winners for their contribution to our community and the wider ecosystem.
Panel:
Marisa Poster Co-Founder at PerfectTed | Forbes 30U30 | GBEA Global Entrepreneur of the Year | Dragons’ Den S’20
Ahana Banerjee Founder & CEO at Clear (YC W21) | Forbes 30u30 | The Sunday Times Young Power List
Valentina Milanova Founder Daye. Removing the pain, shame, and time wasted from gynaecological health
Nell Daly. Founding partner at Revenge Capital
Who should attend?
Female founders in any sector
Women in STEM or any career wanting to be in an inspiring environment
Male allies welcome
This event will naturally have a health, Healthtech, Medtech focus due to who is in the Nexus community but it's open across sectors.
The focus of the panel will primarily be founder / career stories. Fundraising journeys and health experiences.
We're going to be discussing:
-The role of brand and personal brand in D2C health companies
-The decision making on going D2C first and healthtech or medical device later
-Cultural differences to female entrepreneurship in the US vs UK and internationally
-Challenges faced when scaling, sharing practical learnings, especially around fundraising, regulation, and building a team
-What are the biggest gaps and opportunities in women’s health right now
-Highlighting the importance of patient-led design and how we keep the end user front and centre as you grow
-Sustainability and why it matters
Timings
5.30pm-6pm. Arrivals, Making new friends. F+B
6pm-6.10pm. Welcome + Introductions
6.10pm-6.25pm. Community award winners announcements
6.30pm-7.45pm. Panel discussion and Q+A
7.45pm-8.30pm. Making new friends. F+B
8.45pm - Optional pub to continue networking
Organized by Nexus in collaboration with Barclays Innovation Hub and Revenge Capital
-----
Organizer profiles:
Leo Tyson. Nexus Co-founder
Ben Reasbeck. Head of Healthtech and Life Science at Barclays UK
And the rest of the team at Barclays Eagle Labs
Revenge Capital is a £50M evergreen, nonpartisan, sector-agnostic, global impact fund, that invests into overlooked founders: women, BAME, BIPOC, LGBTQIA+, disabled individuals, neurodiverse, anti-ageist, untraditionally educated, socio-economically disadvantaged.